Medtech grants

Between cycles

Gives Liverpool health start-ups up to £50,000 zero-equity cash plus £10,000 R&D vouchers.

Between cycles

Supports physicians entering inherited retinal degeneration subspecialty training to build clinician-scientists for vision-preserving therapies.

Between cycles

Funds Duke faculty, staff, students and trainees $25,000 to $60,000 a year to pilot practical healthcare innovation projects inside Duke's clinical enterprise.

Between cycles

Supports United Kingdom cancer science programmes with multi-stage funding for innovation in disease biology.

Between cycles

Funds disease-model development programs for IRD and AMD translational research.

Between cycles

Funds non-drug research that removes a barrier to diagnosing, monitoring or accurately predicting the course of Alzheimer's disease and related dementias.

Between cycles

Funds developing or validating the biomarkers and outcome measures that make ALS clinical trials sharper, not the trials themselves.

Between cycles

Funds a phase 1 or small phase 2 ALS clinical trial that must start within a year of the award, with a biomarker built in for any drug, biologic or device.

Between cycles

Funds a clinical trial of a new autism treatment, product or device, from a small proof-of-concept study up to a full efficacy trial.

Between cycles

Funds preclinical or clinical Duchenne muscular dystrophy research, at a smaller or a larger funding level.

Between cycles

Funds turning preclinical burn-care findings into an actual product — a device, a drug, or a clinical practice guideline.

Between cycles

Funds clinical trials of ovarian cancer drugs, biologics, devices or guidance, from small pilots to large efficacy studies.

Between cycles

Funds cancer clinical trials from first-in-human through phase III, with regulatory filings already due at the application deadline.

Between cycles

Funds a multi-investigator platform product through translational and early-phase trials, with each partnering investigator on a separate award.

Between cycles

Funds either a drug-discovery study or a clinical diagnostic approach for Lyme disease and other tick-borne diseases, aimed at something a clinic could use.

Between cycles

Funds a clinical trial for psychological health conditions or traumatic brain injury, at a pilot or a larger effectiveness scale the applicant chooses.

Between cycles

Funds Duke BME and clinical faculty teams translating bioengineering research toward patient benefit and commercial products.

Between cycles

Supports cancer detection and diagnosis innovation in the United Kingdom through transformational early development programmes.

Between cycles

Funds research into what is driving more non-hereditary cancers in 18-to-49-year-olds, and how to catch them earlier.

Between cycles

Supports young Korean startups with commercialization funding and mentorship during early commercialization and customer validation.

Between cycles

Invests research teams and institutions for EB Research Project Grants in biotechnology, medical technology, and synthetic biology.

Between cycles

Runs research teams and institutions for EBCRC Grants in biotechnology and medical technology.

Between cycles

Supports Utah businesses in targeted industries with competitive grants for projects that build jobs and local economic opportunity.

Between cycles

Connects teams delivering high impact prototypes with milestone support for EDGE Grant Competition in artificial intelligence, biotechnology, and hardware.